ISCTM Poster Guidelines-Amsterdam
ISCTM Guidelines for submission and preparation of Poster (Link to submission form at bottom of this page)
The goals of the ISCTM, which emphasize methodological analyses, strategies, and applications in clinical trials in CNS disorders, result in challenges and some differences in priorities from those commonly occurring in most scientific organizations which include CNS disorders in their organizational aims. The ISCTM is more likely to have memberships from corporations which have methodological capabilities as a focus of their corporate activities. Such commercial interests are fully justifiable. Within the structure of the ISCTM, our policies, listed below, are intended to avoid any practice which is promotional of, or could be perceived as promotional of an individual’s or firm’s commercial interests.
TITLE: The title of a presentation and or abstract should be free of commercial information. The number of characters, inclusive of spaces, should not exceed 130.
LOGOS and ACADEMIC SEALS: Logos and seals should be limited to ones which are not intended for, or could be interpreted as promoting commercial interests. The size of logos should not be dominant and may only appear at the bottom of the poster.
AUTHORS AND AFFILIATIONS: List authors names without degrees. Include initials without periods (e.g. Abrams, BC). Affiliations of authors should be noted by superscripts in author lines, and detailed in smaller font below the author lines.
SUBMISSION DEADLINE AND NOTIFICATION: Abstract submission deadline – Wednesday, 15 July 2015. Notifications will be sent no later than Monday, 27 July 2015.
QUALIFICATIONS FOR AUTHORSHIP: Those listed as authors must have contributed to each of these areas: Conception and design, data analysis and interpretation, drafting or revision of the poster. In addition, each author must approve the final version of the poster. For clinical studies, this policy will generally result in authorship both by investigators not affiliated with a sponsor as well as scientific personnel of the sponsoring organization(s).
FORMAT AND LENGTH:
Abstract
-Organize the abstract with the following sections:
- The Methodological Question Being Addressed
- Introduction (Aims)
- Methods
- Results
- Conclusions
- Disclosures* if applicable
-Word limit, exclusive of title, authors and references sections, should be less than 500 words. We recommend no references or figures for abstracts. However short tables and up to 2 references, sufficient to locate the article, may be included.
Poster:
-Posters are Vertical, not to exceed 95 cm (3’1″) horizontal and 140 cm (4′ 7″) vertical
-To insure easy viewing of the poster, please use font size of 16 or greater for all sections except references, Table/Figure legends and superscripts for references (which may be smaller font size but should still be easily viewable).
-Narratives in all sections of the poster should refrain from statements that could be perceived as promotional or seeking commercial advantage. As example, “Treatment X represents a new efficacious and well tolerated first line treatment for early Alzheimer’s disease” would go beyond the conclusions possible from a single clinical trial. Additionally, words or phrases which have been patented should be avoided.
-QR Code linking to electronic version of poster is permissible.
*Disclosure: A concluding Acknowledgment should be made regarding source of support and any individuals or organizations who aided a body of work. Along with this statement each poster shall include one of the following statements along the bottom of the poster. If the second option is applicable, then disclosure must be included as part of the abstract.
1. “The authors report no conflicts of interest for this work” or
2. “One or more authors report potential conflicts which are described in the program”
The Scientific Program Committee appreciates very much your cooperation in complying with these guidelines.